{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:22:34Z","timestamp":1793481754466,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00702-025-02901-7","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T09:07:56Z","timestamp":1741252076000},"page":"519-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nutritional and dietary clinical trials for Parkinson's disease: a narrative review"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-9979","authenticated-orcid":false,"given":"Alexandros","family":"Giannakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chondrogiorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiridon","family":"Konitsiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1002\/jsfa.11372","volume":"101","author":"ME Abd El-Hack","year":"2021","unstructured":"Abd El-Hack ME, El-Saadony MT, Swelum AA et al (2021) Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric 101:5747\u20135762. https:\/\/doi.org\/10.1002\/jsfa.11372","journal-title":"J Sci Food Agric"},{"key":"2901_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502357","volume":"54","author":"G Adani","year":"2020","unstructured":"Adani G, Filippini T, Michalke B, Vinceti M (2020) Selenium and Other Trace Elements in the Etiology of Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis of Case-Control Studies. Neuroepidemiology 54:1\u201323. https:\/\/doi.org\/10.1159\/000502357","journal-title":"Neuroepidemiology"},{"key":"2901_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.24918","volume":"27","author":"RN Alcalay","year":"2012","unstructured":"Alcalay RN, Gu Y, Mejia-Santana H et al (2012) The association between Mediterranean diet adherence and Parkinson\u2019s disease. Move Dis 27:771\u2013774. https:\/\/doi.org\/10.1002\/mds.24918","journal-title":"Move Dis"},{"key":"2901_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1063","author":"HM Al-kuraishy","year":"2023","unstructured":"Al-kuraishy HM, Al-Gareeb AI, Alexiou A et al (2023) Pros and cons for statins use and risk of Parkinson\u2019s disease: An updated perspective. Pharmacol Res Perspect. https:\/\/doi.org\/10.1002\/prp2.1063","journal-title":"Pharmacol Res Perspect"},{"key":"2901_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clinthera.2017.11.004","volume":"40","author":"AW Amara","year":"2018","unstructured":"Amara AW, Memon AA (2018) Effects of Exercise on Non-motor Symptoms in Parkinson\u2019s Disease. Clin Ther 40:8\u201315. https:\/\/doi.org\/10.1016\/j.clinthera.2017.11.004","journal-title":"Clin Ther"},{"key":"2901_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","volume":"207","author":"G Anderson","year":"2007","unstructured":"Anderson G, Noorian A, Taylor G et al (2007) Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson\u2019s disease. Exp Neurol 207:4\u201312. https:\/\/doi.org\/10.1016\/j.expneurol.2007.05.010","journal-title":"Exp Neurol"},{"key":"2901_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/medicina60010115","volume":"60","author":"E Angelopoulou","year":"2024","unstructured":"Angelopoulou E, Bougea A, Hatzimanolis A et al (2024) Mild Behavioral Impairment in Parkinson\u2019s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects. Medicina (B Aires) 60:115. https:\/\/doi.org\/10.3390\/medicina60010115","journal-title":"Medicina (B Aires)"},{"key":"2901_CR8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archneurol.2009.247","volume":"66","author":"A Ascherio","year":"2009","unstructured":"Ascherio A, LeWitt PA, Xu K et al (2009) Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 66:1460\u20131468. https:\/\/doi.org\/10.1001\/archneurol.2009.247","journal-title":"Arch Neurol"},{"key":"2901_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10654-023-00970-0","volume":"38","author":"D Aune","year":"2023","unstructured":"Aune D, Schlesinger S, Mahamat-Saleh Y et al (2023) Diabetes mellitus, prediabetes and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases. Eur J Epidemiol 38:591\u2013604. https:\/\/doi.org\/10.1007\/s10654-023-00970-0","journal-title":"Eur J Epidemiol"},{"key":"2901_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2018.09.009","volume":"15","author":"GM Babulal","year":"2019","unstructured":"Babulal GM, Quiroz YT, Albensi BC et al (2019) Perspectives on ethnic and racial disparities in Alzheimer\u2019s disease and related dementias: Update and areas of immediate need. Alzheimer\u2019s & Dementia 15:292\u2013312. https:\/\/doi.org\/10.1016\/j.jalz.2018.09.009","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2901_CR11","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/mds.21003","volume":"21","author":"M Barichella","year":"2006","unstructured":"Barichella M, Marczewska A, De Notaris R et al (2006) Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson\u2019s disease. Move Dis 21:1682\u20131687. https:\/\/doi.org\/10.1002\/mds.21003","journal-title":"Move Dis"},{"key":"2901_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/10284150701414046","volume":"10","author":"M Barichella","year":"2007","unstructured":"Barichella M, Savardi C, Mauri A et al (2007) Diet with LPP for renal patients increases daily energy expenditure and improves motor function in Parkinsonian patients with motor fluctuations. Nutr Neurosci 10:129\u2013135. https:\/\/doi.org\/10.1080\/10284150701414046","journal-title":"Nutr Neurosci"},{"key":"2901_CR13","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","volume":"87","author":"M Barichella","year":"2016","unstructured":"Barichella M, Pacchetti C, Bolliri C et al (2016) Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology 87:1274\u20131280. https:\/\/doi.org\/10.1212\/WNL.0000000000003127","journal-title":"Neurology"},{"key":"2901_CR14","doi-asserted-by":"publisher","first-page":"E485","DOI":"10.1212\/WNL.0000000000007858","volume":"93","author":"M Barichella","year":"2019","unstructured":"Barichella M, Cereda E, Pinelli G et al (2019) Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome. Neurology 93:E485\u2013E496. https:\/\/doi.org\/10.1212\/WNL.0000000000007858","journal-title":"Neurology"},{"key":"2901_CR15","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. The Lancet 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"The Lancet"},{"key":"2901_CR16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jama.2021.10207","volume":"326","author":"B Bluett","year":"2021","unstructured":"Bluett B, Togasaki DM, Mihaila D et al (2021) Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression. JAMA 326:926. https:\/\/doi.org\/10.1001\/jama.2021.10207","journal-title":"JAMA"},{"key":"2901_CR17","first-page":"289","volume":"21","author":"S Borzabadi","year":"2018","unstructured":"Borzabadi S, Oryan S, Eidi A et al (2018) The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin and Lipid in Patients with Parkinson\u2019s Disease: A Randomized, Double-blind, PlaceboControlled Trial. Arch Iran Med 21:289\u2013295","journal-title":"Arch Iran Med"},{"key":"2901_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U et al (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"key":"2901_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RAI, Bohl J, Del Tredici K (2006) Gastric \u03b1-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 396:67\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.012","journal-title":"Neurosci Lett"},{"key":"2901_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clnu.2017.09.003","volume":"37","author":"R Burgos","year":"2018","unstructured":"Burgos R, Bret\u00f3n I, Cereda E et al (2018) ESPEN guideline clinical nutrition in neurology. Clin Nutr 37:354\u2013396. https:\/\/doi.org\/10.1016\/j.clnu.2017.09.003","journal-title":"Clin Nutr"},{"key":"2901_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ijms18030551","volume":"18","author":"R Cacabelos","year":"2017","unstructured":"Cacabelos R (2017) Parkinson\u2019s Disease: From Pathogenesis to Pharmacogenomics. Int J Mol Sci 18:551. https:\/\/doi.org\/10.3390\/ijms18030551","journal-title":"Int J Mol Sci"},{"key":"2901_CR22","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/nu14071467","volume":"14","author":"G Caioni","year":"2022","unstructured":"Caioni G, Cimini A, Benedetti E (2022) Food Contamination: An Unexplored Possible Link between Dietary Habits and Parkinson\u2019s Disease. Nutrients 14:1467. https:\/\/doi.org\/10.3390\/nu14071467","journal-title":"Nutrients"},{"key":"2901_CR23","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s13311-021-01067-w","volume":"18","author":"A Choi","year":"2021","unstructured":"Choi A, Hallett M, Ehrlich D (2021) Nutritional Ketosis in Parkinson\u2019s Disease \u2014 a Review of Remaining Questions and Insights. Neurotherapeutics 18:1637\u20131649. https:\/\/doi.org\/10.1007\/s13311-021-01067-w","journal-title":"Neurotherapeutics"},{"key":"2901_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03603-5","author":"AH Choi","year":"2024","unstructured":"Choi AH, Delgado M, Chen KY et al (2024) A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson\u2019s disease. BMC Neurol. https:\/\/doi.org\/10.1186\/s12883-024-03603-5","journal-title":"BMC Neurol"},{"key":"2901_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1212\/WNL.0000000000004175","volume":"89","author":"R Cilia","year":"2017","unstructured":"Cilia R, Laguna J, Cassani E et al (2017) Mucuna pruriens in Parkinson disease. Neurology 89:432\u2013438. https:\/\/doi.org\/10.1212\/WNL.0000000000004175","journal-title":"Neurology"},{"key":"2901_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2018.01.014","volume":"49","author":"R Cilia","year":"2018","unstructured":"Cilia R, Laguna J, Cassani E et al (2018) Daily intake of Mucuna pruriens in advanced Parkinson\u2019s disease: A 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord 49:60\u201366. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.01.014","journal-title":"Parkinsonism Relat Disord"},{"key":"2901_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clnesp.2022.01.023","volume":"48","author":"S Coe","year":"2022","unstructured":"Coe S, Andreoli D, George M et al (2022) A feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue and fatigability in people with Parkinson\u2019s (pwP). Clin Nutr ESPEN 48:68\u201373. https:\/\/doi.org\/10.1016\/j.clnesp.2022.01.023","journal-title":"Clin Nutr ESPEN"},{"key":"2901_CR28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.clnu.2014.12.007","volume":"34","author":"A Cucca","year":"2015","unstructured":"Cucca A, Mazzucco S, Bursomanno A et al (2015) Amino acid supplementation in l-dopa treated Parkinson\u2019s disease patients. Clin Nutr 34:1189\u20131194. https:\/\/doi.org\/10.1016\/j.clnu.2014.12.007","journal-title":"Clin Nutr"},{"key":"2901_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","volume":"111","author":"TM da Silva","year":"2008","unstructured":"da Silva TM, Munhoz RP, Alvarez C et al (2008) Depression in Parkinson\u2019s disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord 111:351\u2013359. https:\/\/doi.org\/10.1016\/j.jad.2008.03.008","journal-title":"J Affect Disord"},{"key":"2901_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000333790","volume":"10","author":"J DiFrancisco-Donoghue","year":"2012","unstructured":"DiFrancisco-Donoghue J, Lamberg EM, Rabin E et al (2012) Effects of exercise and B vitamins on homocysteine and glutathione in Parkinson\u2019s disease: A randomized trial. Neurodegener Dis 10:127\u2013134. https:\/\/doi.org\/10.1159\/000333790","journal-title":"Neurodegener Dis"},{"key":"2901_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X et al (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8:73. https:\/\/doi.org\/10.1038\/s41392-023-01353-3","journal-title":"Signal Transduct Target Ther"},{"key":"2901_CR32","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"key":"2901_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T et al (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"2901_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1472-6882-14-296","volume":"14","author":"MN Fernandez-Martinez","year":"2014","unstructured":"Fernandez-Martinez MN, Hernandez-Echevarria L, Sierra-Vega M et al (2014) A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters. BMC Comp Altern Med 14:296. https:\/\/doi.org\/10.1186\/1472-6882-14-296","journal-title":"BMC Comp Altern Med"},{"key":"2901_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","volume":"9","author":"JB Furness","year":"2012","unstructured":"Furness JB (2012) The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9:286\u2013294. https:\/\/doi.org\/10.1038\/nrgastro.2012.32","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2901_CR36","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/CIA.S106284","volume":"11","author":"D Georgescu","year":"2016","unstructured":"Georgescu D, Ancusa OE, Georgescu LA et al (2016) Nonmotor gastrointestinal disorders in older patients with Parkinson\u2019s disease: Is there hope? Clin Interv Aging 11:1601\u20131608. https:\/\/doi.org\/10.2147\/CIA.S106284","journal-title":"Clin Interv Aging"},{"key":"2901_CR37","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-Sponsored Revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Move Dis 23:2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Move Dis"},{"key":"2901_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36497-x","author":"DA Hall","year":"2023","unstructured":"Hall DA, Voigt RM, Cantu-Jungles TM et al (2023) An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson\u2019s disease participants. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-36497-x","journal-title":"Nat Commun"},{"key":"2901_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/467131","volume":"2014","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Gordon MF, Mizuno Y et al (2014) Minimal Clinically Important Difference in Parkinson\u2019s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release. Parkinsons Dis 2014:1\u20138. https:\/\/doi.org\/10.1155\/2014\/467131","journal-title":"Parkinsons Dis"},{"key":"2901_CR40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2901_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020376","author":"T Hegelmaier","year":"2020","unstructured":"Hegelmaier T, Lebbing M, Duscha A et al (2020) Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson\u2019s Disease. Cells. https:\/\/doi.org\/10.3390\/cells9020376","journal-title":"Cells"},{"key":"2901_CR42","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY et al (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 97:2499\u20132574. https:\/\/doi.org\/10.1007\/s00204-023-03562-9","journal-title":"Arch Toxicol"},{"key":"2901_CR43","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. The Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"The Lancet"},{"key":"2901_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1118529","author":"K Kasarello","year":"2023","unstructured":"Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K (2023) Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1118529","journal-title":"Front Microbiol"},{"key":"2901_CR45","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.3390\/ijms24108827","volume":"24","author":"SW Kim","year":"2023","unstructured":"Kim SW, Lee JH, Kim B et al (2023) Natural Products as the Potential to Improve Alzheimer\u2019s and Parkinson\u2019s Disease. Int J Mol Sci 24:8827. https:\/\/doi.org\/10.3390\/ijms24108827","journal-title":"Int J Mol Sci"},{"key":"2901_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N et al (2021) Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener 16:83. https:\/\/doi.org\/10.1186\/s13024-021-00501-z","journal-title":"Mol Neurodegener"},{"key":"2901_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.55544\/jrasb.3.2.43","volume":"3","author":"V Kumar","year":"2024","unstructured":"Kumar V, Gupta H, Anamika Kumar R (2024) Therapeutic Approaches of Nutraceuticals in Neurological Disorders: A Review. J Res Appl Sci Biotechnol 3:261\u2013281. https:\/\/doi.org\/10.55544\/jrasb.3.2.43","journal-title":"J Res Appl Sci Biotechnol"},{"key":"2901_CR48","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/nu15061436","volume":"15","author":"A Kurowska","year":"2023","unstructured":"Kurowska A, Ziemich\u00f3d W, Herbet M, Pi\u0105tkowska-Chmiel I (2023) The Role of Diet as a Modulator of the Inflammatory Process in the Neurological Diseases. Nutrients 15:1436. https:\/\/doi.org\/10.3390\/nu15061436","journal-title":"Nutrients"},{"key":"2901_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00394-019-02095-1","volume":"58","author":"R Landberg","year":"2019","unstructured":"Landberg R, Manach C, Kerckhof F-M et al (2019) Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints. Eur J Nutr 58:21\u201336. https:\/\/doi.org\/10.1007\/s00394-019-02095-1","journal-title":"Eur J Nutr"},{"key":"2901_CR50","doi-asserted-by":"publisher","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","volume":"5","author":"T Lebouvier","year":"2010","unstructured":"Lebouvier T, Neunlist M, Bruley des Varannes S, et al (2010) Colonic Biopsies to Assess the Neuropathology of Parkinson\u2019s Disease and Its Relationship with Symptoms. PLoS One 5:e12728. https:\/\/doi.org\/10.1371\/journal.pone.0012728","journal-title":"PLoS One"},{"key":"2901_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jad.2024.05.096","volume":"359","author":"AP Matison","year":"2024","unstructured":"Matison AP, Flood VM, Lam BCP et al (2024) Associations between fruit and vegetable intakes and incident depression in middle-aged and older adults from 10 diverse international longitudinal cohorts. J Affect Disord 359:373\u2013381. https:\/\/doi.org\/10.1016\/j.jad.2024.05.096","journal-title":"J Affect Disord"},{"key":"2901_CR52","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","volume":"390","author":"WG Meissner","year":"2024","unstructured":"Meissner WG, Remy P, Giordana C et al (2024) Trial of Lixisenatide in Early Parkinson\u2019s Disease. New England J Med 390:1176\u20131185. https:\/\/doi.org\/10.1056\/NEJMoa2312323","journal-title":"New England J Med"},{"key":"2901_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6281454","volume":"2020","author":"AG Miranda-D\u00edaz","year":"2020","unstructured":"Miranda-D\u00edaz AG, Garc\u00eda-S\u00e1nchez A, Cardona-Mu\u00f1oz EG (2020) Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson\u2019s Disease. Oxid Med Cell Longev 2020:1\u201317. https:\/\/doi.org\/10.1155\/2020\/6281454","journal-title":"Oxid Med Cell Longev"},{"key":"2901_CR54","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535\u2013b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"2901_CR55","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/biomedicines11061560","volume":"11","author":"M Montanari","year":"2023","unstructured":"Montanari M, Imbriani P, Bonsi P et al (2023) Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson\u2019s Disease from Mice to Human. Biomedicines 11:1560. https:\/\/doi.org\/10.3390\/biomedicines11061560","journal-title":"Biomedicines"},{"key":"2901_CR56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/ijms26010122","volume":"26","author":"M Montanari","year":"2024","unstructured":"Montanari M, Mercuri NB, Martella G (2024) Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson\u2019s Disease and Frailty. Int J Mol Sci 26:122. https:\/\/doi.org\/10.3390\/ijms26010122","journal-title":"Int J Mol Sci"},{"key":"2901_CR57","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/cpt.1548","volume":"106","author":"DA Monti","year":"2019","unstructured":"Monti DA, Zabrecky G, Kremens D et al (2019) N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson\u2019s Disease. Clin Pharmacol Ther 106:884\u2013890. https:\/\/doi.org\/10.1002\/cpt.1548","journal-title":"Clin Pharmacol Ther"},{"key":"2901_CR58","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.3390\/ijms25137183","volume":"25","author":"M Muleiro Alvarez","year":"2024","unstructured":"Muleiro Alvarez M, Cano-Herrera G, Osorio Mart\u00ednez MF et al (2024) A Comprehensive Approach to Parkinson\u2019s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects. Int J Mol Sci 25:7183. https:\/\/doi.org\/10.3390\/ijms25137183","journal-title":"Int J Mol Sci"},{"key":"2901_CR59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ptr.4969","volume":"28","author":"J Nathan","year":"2014","unstructured":"Nathan J, Panjwani S, Mohan V et al (2014) Efficacy and Safety of Standardized Extract of Trigonella foenum-graecum L Seeds as an Adjuvant to L-Dopa in the Management of Patients with Parkinson\u2019s Disease. Phytother Res 28:172\u2013178. https:\/\/doi.org\/10.1002\/ptr.4969","journal-title":"Phytother Res"},{"key":"2901_CR60","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/ijms21072501","volume":"21","author":"T Nury","year":"2020","unstructured":"Nury T, Lizard G, Vejux A (2020) Lipids Nutrients in Parkinson and Alzheimer\u2019s Diseases: Cell Death and Cytoprotection. Int J Mol Sci 21:2501. https:\/\/doi.org\/10.3390\/ijms21072501","journal-title":"Int J Mol Sci"},{"key":"2901_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102366","author":"Z Paknahad","year":"2020","unstructured":"Paknahad Z, Sheklabadi E, Derakhshan Y et al (2020) The effect of the Mediterranean diet on cognitive function in patients with Parkinson\u2019s disease: A randomized clinical controlled trial. Comp Ther Med. https:\/\/doi.org\/10.1016\/j.ctim.2020.102366","journal-title":"Comp Ther Med"},{"key":"2901_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/1028415X.2020.1751509","volume":"25","author":"Z Paknahad","year":"2022","unstructured":"Paknahad Z, Sheklabadi E, Moravejolahkami AR et al (2022) The effects of Mediterranean diet on severity of disease and serum Total Antioxidant Capacity (TAC) in patients with Parkinson\u2019s disease: a single center, randomized controlled trial. Nutr Neurosci 25:313\u2013320. https:\/\/doi.org\/10.1080\/1028415X.2020.1751509","journal-title":"Nutr Neurosci"},{"key":"2901_CR63","doi-asserted-by":"publisher","first-page":"106954","DOI":"10.1016\/j.clineuro.2021.106954","volume":"210","author":"M Pantzaris","year":"2021","unstructured":"Pantzaris M, Loukaides G, Paraskevis D et al (2021) Neuroaspis PLP10TM, a nutritional formula rich in omega-3 and omega-6 fatty acids with antioxidant vitamins including gamma-tocopherol in early Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin Neurol Neurosurg 210:106954. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106954","journal-title":"Clin Neurol Neurosurg"},{"key":"2901_CR64","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1056\/NEJM199301213280305","volume":"328","author":"Parkinson Study Group","year":"1993","unstructured":"Parkinson Study Group (1993) Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson\u2019s Disease. New England J Med 328:176\u2013183. https:\/\/doi.org\/10.1056\/NEJM199301213280305","journal-title":"New England J Med"},{"key":"2901_CR65","doi-asserted-by":"publisher","unstructured":"Perneczky R, Kempermann G, Korczyn AD, et al (2019) Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer\u2019s Association Reserve, Resilience and Protective Factors Professional Interest Area working groups. BMC Med 17: 47. https:\/\/doi.org\/10.1186\/s12916-019-1283-z","DOI":"10.1186\/s12916-019-1283-z"},{"key":"2901_CR66","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.27390","volume":"33","author":"MCL Phillips","year":"2018","unstructured":"Phillips MCL, Murtagh DKJ, Gilbertson LJ et al (2018) Low-fat versus ketogenic diet in Parkinson\u2019s disease: A pilot randomized controlled trial. Move Dis 33:1306\u20131314. https:\/\/doi.org\/10.1002\/mds.27390","journal-title":"Move Dis"},{"key":"2901_CR67","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/00207454.2023.2178433","volume":"134","author":"G Pinelli","year":"2024","unstructured":"Pinelli G, Siri C, Ranghetti A et al (2024) Can we add whey protein supplementation in patients with Parkinson\u2019s disease without interfering with levodopa response? Int J Neurosci 134:973\u2013977. https:\/\/doi.org\/10.1080\/00207454.2023.2178433","journal-title":"Int J Neurosci"},{"key":"2901_CR68","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"2901_CR69","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Move Dis 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Move Dis"},{"key":"2901_CR70","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.3390\/nu14214637","volume":"14","author":"V Puri","year":"2022","unstructured":"Puri V, Nagpal M, Singh I et al (2022) A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges. Nutrients 14:4637. https:\/\/doi.org\/10.3390\/nu14214637","journal-title":"Nutrients"},{"key":"2901_CR71","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41531-023-00541-w","volume":"9","author":"C Rusch","year":"2023","unstructured":"Rusch C, Flanagan R, Suh H, Subramanian I (2023) To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson\u2019s disease. NPJ Parkinsons Dis 9:98. https:\/\/doi.org\/10.1038\/s41531-023-00541-w","journal-title":"NPJ Parkinsons Dis"},{"key":"2901_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/nu16172946","author":"C Rusch","year":"2024","unstructured":"Rusch C, Beke M, Nieves C et al (2024) Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson\u2019s Disease: A Randomized Controlled Trial. Nutrients. https:\/\/doi.org\/10.3390\/nu16172946","journal-title":"Nutrients"},{"key":"2901_CR73","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mds.20352","volume":"20","author":"R Sakakibara","year":"2005","unstructured":"Sakakibara R, Odaka T, Lui Z et al (2005) Dietary herb extract Dai-kenchu-to ameliorates constipation in parkinsonian patients (Parkinson\u2019s disease and multiple system atrophy). Move Dis 20:261\u2013262. https:\/\/doi.org\/10.1002\/mds.20352","journal-title":"Move Dis"},{"key":"2901_CR74","doi-asserted-by":"publisher","first-page":"E1328","DOI":"10.1212\/WNL.0000000000008194","volume":"93","author":"MA Schwarzschild","year":"2019","unstructured":"Schwarzschild MA, MacKlin EA, Bakshi R et al (2019) Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial. Neurology 93:E1328\u2013E1338. https:\/\/doi.org\/10.1212\/WNL.0000000000008194","journal-title":"Neurology"},{"key":"2901_CR75","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3390\/nu16142181","volume":"16","author":"BA Seelarbokus","year":"2024","unstructured":"Seelarbokus BA, Menozzi E, Schapira AHV et al (2024) Mediterranean Diet Adherence, Gut Microbiota and Parkinson\u2019s Disease: A Systematic Review. Nutrients 16:2181. https:\/\/doi.org\/10.3390\/nu16142181","journal-title":"Nutrients"},{"key":"2901_CR76","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/alz.12588","volume":"18","author":"C Sexton","year":"2022","unstructured":"Sexton C, Solis M, Aharon-Peretz J et al (2022) Alzheimer\u2019s disease research progress in the Mediterranean region: The Alzheimer\u2019s Association International Conference Satellite Symposium. Alzheimer\u2019s & Dementia 18:1957\u20131968. https:\/\/doi.org\/10.1002\/alz.12588","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2901_CR77","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12883-014-0212-1","volume":"14","author":"JM Sheard","year":"2014","unstructured":"Sheard JM, Ash S, Mellick GD et al (2014) Improved nutritional status is related to improved quality of life in Parkinson\u2019s disease. BMC Neurol 14:212. https:\/\/doi.org\/10.1186\/s12883-014-0212-1","journal-title":"BMC Neurol"},{"key":"2901_CR78","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuint.2017.03.014","volume":"108","author":"M Taghizadeh","year":"2017","unstructured":"Taghizadeh M, Tamtaji OR, Dadgostar E et al (2017) The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Neurochem Int 108:183\u2013189. https:\/\/doi.org\/10.1016\/j.neuint.2017.03.014","journal-title":"Neurochem Int"},{"key":"2901_CR79","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/advances\/nmac001","volume":"13","author":"S Talebi","year":"2022","unstructured":"Talebi S, Ghoreishy SM, Jayedi A et al (2022) Dietary Antioxidants and Risk of Parkinson\u2019s Disease: A Systematic Review and Dose-Response Meta-analysis of Observational Studies. Adv Nutr 13:1493\u20131504. https:\/\/doi.org\/10.1093\/advances\/nmac001","journal-title":"Adv Nutr"},{"key":"2901_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.clineuro.2018.12.006","volume":"176","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Aghadavod E et al (2019) The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin Neurol Neurosurg 176:116\u2013121. https:\/\/doi.org\/10.1016\/j.clineuro.2018.12.006","journal-title":"Clin Neurol Neurosurg"},{"key":"2901_CR81","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R et al (2019) Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr 38:1031\u20131035. https:\/\/doi.org\/10.1016\/j.clnu.2018.05.018","journal-title":"Clin Nutr"},{"key":"2901_CR82","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan AH, Lim SY, Lang AE (2022) The microbiome\u2013gut\u2013brain axis in Parkinson disease \u2014 from basic research to the clinic. Nat Rev Neurol 18:476\u2013495. https:\/\/doi.org\/10.1038\/s41582-022-00681-2","journal-title":"Nat Rev Neurol"},{"key":"2901_CR83","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/ijms23031184","volume":"23","author":"ARL Toledo","year":"2022","unstructured":"Toledo ARL, Monroy GR, Salazar FE et al (2022) Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders. Int J Mol Sci 23:1184. https:\/\/doi.org\/10.3390\/ijms23031184","journal-title":"Int J Mol Sci"},{"key":"2901_CR84","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"2901_CR85","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.3233\/JPD-230264","volume":"14","author":"KN Tosefsky","year":"2024","unstructured":"Tosefsky KN, Zhu J, Wang YN et al (2024) The Role of Diet in Parkinson\u2019s Disease. J Parkinsons Dis 14:S21\u2013S34. https:\/\/doi.org\/10.3233\/JPD-230264","journal-title":"J Parkinsons Dis"},{"key":"2901_CR86","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jns.2016.05.056","volume":"367","author":"P Tosukhowong","year":"2016","unstructured":"Tosukhowong P, Boonla C, Dissayabutra T et al (2016) Biochemical and clinical effects of Whey protein supplementation in Parkinson\u2019s disease: A pilot study. J Neurol Sci 367:162\u2013170. https:\/\/doi.org\/10.1016\/j.jns.2016.05.056","journal-title":"J Neurol Sci"},{"key":"2901_CR87","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1212\/WNL.39.4.549","volume":"39","author":"JK Tsui","year":"1989","unstructured":"Tsui JK, Ross S, Poulin K et al (1989) The effect of dietary protein on the efficacy of L-dopa. Neurology 39:549\u2013549. https:\/\/doi.org\/10.1212\/WNL.39.4.549","journal-title":"Neurology"},{"key":"2901_CR88","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s10072-023-07278-7","volume":"45","author":"I Ullah","year":"2024","unstructured":"Ullah I, Wang X, Li H (2024) Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms. Neurol Sci 45:2979\u20132995. https:\/\/doi.org\/10.1007\/s10072-023-07278-7","journal-title":"Neurol Sci"},{"key":"2901_CR89","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/foods10061231","volume":"10","author":"M Valero-Vello","year":"2021","unstructured":"Valero-Vello M, Peris-Mart\u00ednez C, Garc\u00eda-Medina JJ et al (2021) Searching for the Antioxidant, Anti-Inflammatory, and Neuroprotective Potential of Natural Food and Nutritional Supplements for Ocular Health in the Mediterranean Population. Foods 10:1231. https:\/\/doi.org\/10.3390\/foods10061231","journal-title":"Foods"},{"key":"2901_CR90","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230366","author":"I Van Der Berg","year":"2024","unstructured":"Van Der Berg I, Schootemeijer S, Overbeek K et al (2024) Dietary Interventions in Parkinson\u2019s Disease. J Parkinsons Dis. https:\/\/doi.org\/10.3233\/JPD-230366","journal-title":"J Parkinsons Dis"},{"key":"2901_CR91","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","volume":"64","author":"TB VanItallie","year":"2005","unstructured":"VanItallie TB, Nonas C, Di Rocco A et al (2005) Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study. Neurology 64:728\u2013730. https:\/\/doi.org\/10.1212\/01.WNL.0000152046.11390.45","journal-title":"Neurology"},{"key":"2901_CR92","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/ajcn\/70.5.793","volume":"70","author":"GT Vatassery","year":"1999","unstructured":"Vatassery GT, Bauer T, Dysken M (1999) High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr 70:793\u2013801. https:\/\/doi.org\/10.1093\/ajcn\/70.5.793","journal-title":"Am J Clin Nutr"},{"key":"2901_CR93","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00437-22","author":"A Walker","year":"2023","unstructured":"Walker A, Czyz DM (2023) Oh my gut! Is the microbial origin of neurodegenerative diseases real? Infect Immun. https:\/\/doi.org\/10.1128\/iai.00437-22","journal-title":"Infect Immun"},{"key":"2901_CR94","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s00415-012-6527-1","volume":"259","author":"M Wolz","year":"2012","unstructured":"Wolz M, Schleiffer C, Klingelh\u00f6fer L et al (2012) Comparison of chocolate to cacao-free white chocolate in Parkinson\u2019s disease: A single-dose, investigator-blinded, placebo-controlled, crossover trial. J Neurol 259:2447\u20132451. https:\/\/doi.org\/10.1007\/s00415-012-6527-1","journal-title":"J Neurol"},{"key":"2901_CR95","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1039\/D3FO00728F","volume":"14","author":"X Yang","year":"2023","unstructured":"Yang X, He X, Xu S et al (2023) Effect of Lacticaseibacillus paracasei strain Shirota supplementation on clinical responses and gut microbiome in Parkinson\u2019s disease. Food Funct 14:6828\u20136839. https:\/\/doi.org\/10.1039\/D3FO00728F","journal-title":"Food Funct"},{"key":"2901_CR96","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/alz.12845","volume":"19","author":"HN Yassine","year":"2023","unstructured":"Yassine HN, Self W, Kerman BE et al (2023) Nutritional metabolism and cerebral bioenergetics in Alzheimer\u2019s disease and related dementias. Alzheimer\u2019s & Dementia 19:1041\u20131066. https:\/\/doi.org\/10.1002\/alz.12845","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2901_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.955919","author":"J Zeng","year":"2022","unstructured":"Zeng J, Wang X, Pan F, Mao Z (2022) The relationship between Parkinson\u2019s disease and gastrointestinal diseases. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.955919","journal-title":"Front Aging Neurosci"},{"key":"2901_CR98","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12031-011-9560-0","volume":"47","author":"HC Zhu","year":"2012","unstructured":"Zhu HC, Zhao J, Luo CY, Li QQ (2012) Gastrointestinal Dysfunction in a Parkinson\u2019s Disease Rat Model and the Changes of Dopaminergic, Nitric Oxidergic, and Cholinergic Neurotransmitters in Myenteric Plexus. J Mol Neurosci 47:15\u201325. https:\/\/doi.org\/10.1007\/s12031-011-9560-0","journal-title":"J Mol Neurosci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02901-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T15:14:23Z","timestamp":1741965263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02901-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02901-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our institution does not require ethical approval for narrative reviews.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}